Selected research
Industry Growth & Trends
Global Glass Vial for Vaccine Industry Growth and Trends Forecast to 2032
Market perspective
The global Glass Vial for Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glass Vial for Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Glass Vial for Vaccine include Schott AG, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma and Piramal Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Glass Vial for Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Glass Vial for Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glass Vial for Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glass Vial for Vaccine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Glass Vial for Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Glass Vial for Vaccine Market by Company
Schott AG
DWK Life Sciences
Richland Glass
Nipro
Pacific Vial Manufacturing
Origin Ltd
Stevanato Group
SGD Pharma
Piramal Glass
Zheng Chuan
Shandong Pharmaceutical Glass
Zheng Li
Gerresheimer
Four Stars Glass
JOTOP Glass
Glass Vial for Vaccine Segment by Type
Molded Glass Vial
Tubular Glass Vial
Glass Vial for Vaccine Segment by Application
Preventive Vaccine
Therapeutic Vaccine
Glass Vial for Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glass Vial for Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glass Vial for Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glass Vial for Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glass Vial for Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glass Vial for Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Molded Glass Vial
- Tubular Glass Vial
Applications
- Preventive Vaccine
- Therapeutic Vaccine
Companies covered
- Schott AG
- DWK Life Sciences
- Richland Glass
- Nipro
- Pacific Vial Manufacturing
- Origin Ltd
- Stevanato Group
- SGD Pharma
- Piramal Glass
- Zheng Chuan
- Shandong Pharmaceutical Glass
- Zheng Li
- Gerresheimer
- Four Stars Glass
- JOTOP Glass
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glass Vial for Vaccine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Glass Vial for Vaccine Sales Estimates and Forecasts (2021-2032)
- 1.3 Glass Vial for Vaccine Market by Type
- 1.3.1 Molded Glass Vial
- 1.3.2 Tubular Glass Vial
- 1.4 Global Glass Vial for Vaccine Market Size by Type
- 1.4.1 Global Glass Vial for Vaccine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Glass Vial for Vaccine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Glass Vial for Vaccine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Glass Vial for Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Glass Vial for Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Glass Vial for Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Glass Vial for Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Glass Vial for Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Glass Vial for Vaccine Industry Trends
- 2.2 Glass Vial for Vaccine Industry Drivers
- 2.3 Glass Vial for Vaccine Industry Opportunities and Challenges
- 2.4 Glass Vial for Vaccine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Glass Vial for Vaccine Revenue (2021-2026)
- 3.2 Global Top Players by Glass Vial for Vaccine Sales (2021-2026)
- 3.3 Global Top Players by Glass Vial for Vaccine Price (2021-2026)
- 3.4 Global Glass Vial for Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glass Vial for Vaccine Major Company Production Sites & Headquarters
- 3.6 Global Glass Vial for Vaccine Company, Product Type & Application
- 3.7 Global Glass Vial for Vaccine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glass Vial for Vaccine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glass Vial for Vaccine Players Market Share by Revenue in 2025
- 3.8.3 2025 Glass Vial for Vaccine Tier 1, Tier 2, and Tier 3
4 Glass Vial for Vaccine Regional Status and Outlook
- 4.1 Global Glass Vial for Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Glass Vial for Vaccine Historic Market Size by Region
- 4.2.1 Global Glass Vial for Vaccine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Glass Vial for Vaccine Sales in Value by Region (2021-2026)
- 4.2.3 Global Glass Vial for Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Glass Vial for Vaccine Forecasted Market Size by Region
- 4.3.1 Global Glass Vial for Vaccine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Glass Vial for Vaccine Sales in Value by Region (2027-2032)
- 4.3.3 Global Glass Vial for Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glass Vial for Vaccine by Application
- 5.1 Glass Vial for Vaccine Market by Application
- 5.1.1 Preventive Vaccine
- 5.1.2 Therapeutic Vaccine
- 5.2 Global Glass Vial for Vaccine Market Size by Application
- 5.2.1 Global Glass Vial for Vaccine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Glass Vial for Vaccine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Glass Vial for Vaccine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Glass Vial for Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Glass Vial for Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Glass Vial for Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Glass Vial for Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Glass Vial for Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Schott AG
- 6.1.1 Schott AG Company Information
- 6.1.2 Schott AG Business Overview
- 6.1.3 Schott AG Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Schott AG Glass Vial for Vaccine Product Portfolio
- 6.1.5 Schott AG Recent Developments
- 6.2 DWK Life Sciences
- 6.2.1 DWK Life Sciences Company Information
- 6.2.2 DWK Life Sciences Business Overview
- 6.2.3 DWK Life Sciences Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 DWK Life Sciences Glass Vial for Vaccine Product Portfolio
- 6.2.5 DWK Life Sciences Recent Developments
- 6.3 Richland Glass
- 6.3.1 Richland Glass Company Information
- 6.3.2 Richland Glass Business Overview
- 6.3.3 Richland Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Richland Glass Glass Vial for Vaccine Product Portfolio
- 6.3.5 Richland Glass Recent Developments
- 6.4 Nipro
- 6.4.1 Nipro Company Information
- 6.4.2 Nipro Business Overview
- 6.4.3 Nipro Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Nipro Glass Vial for Vaccine Product Portfolio
- 6.4.5 Nipro Recent Developments
- 6.5 Pacific Vial Manufacturing
- 6.5.1 Pacific Vial Manufacturing Company Information
- 6.5.2 Pacific Vial Manufacturing Business Overview
- 6.5.3 Pacific Vial Manufacturing Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Pacific Vial Manufacturing Glass Vial for Vaccine Product Portfolio
- 6.5.5 Pacific Vial Manufacturing Recent Developments
- 6.6 Origin Ltd
- 6.6.1 Origin Ltd Company Information
- 6.6.2 Origin Ltd Business Overview
- 6.6.3 Origin Ltd Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Origin Ltd Glass Vial for Vaccine Product Portfolio
- 6.6.5 Origin Ltd Recent Developments
- 6.7 Stevanato Group
- 6.7.1 Stevanato Group Company Information
- 6.7.2 Stevanato Group Business Overview
- 6.7.3 Stevanato Group Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Stevanato Group Glass Vial for Vaccine Product Portfolio
- 6.7.5 Stevanato Group Recent Developments
- 6.8 SGD Pharma
- 6.8.1 SGD Pharma Company Information
- 6.8.2 SGD Pharma Business Overview
- 6.8.3 SGD Pharma Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 SGD Pharma Glass Vial for Vaccine Product Portfolio
- 6.8.5 SGD Pharma Recent Developments
- 6.9 Piramal Glass
- 6.9.1 Piramal Glass Company Information
- 6.9.2 Piramal Glass Business Overview
- 6.9.3 Piramal Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Piramal Glass Glass Vial for Vaccine Product Portfolio
- 6.9.5 Piramal Glass Recent Developments
- 6.10 Zheng Chuan
- 6.10.1 Zheng Chuan Company Information
- 6.10.2 Zheng Chuan Business Overview
- 6.10.3 Zheng Chuan Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Zheng Chuan Glass Vial for Vaccine Product Portfolio
- 6.10.5 Zheng Chuan Recent Developments
- 6.11 Shandong Pharmaceutical Glass
- 6.11.1 Shandong Pharmaceutical Glass Company Information
- 6.11.2 Shandong Pharmaceutical Glass Business Overview
- 6.11.3 Shandong Pharmaceutical Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Shandong Pharmaceutical Glass Glass Vial for Vaccine Product Portfolio
- 6.11.5 Shandong Pharmaceutical Glass Recent Developments
- 6.12 Zheng Li
- 6.12.1 Zheng Li Company Information
- 6.12.2 Zheng Li Business Overview
- 6.12.3 Zheng Li Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Zheng Li Glass Vial for Vaccine Product Portfolio
- 6.12.5 Zheng Li Recent Developments
- 6.13 Gerresheimer
- 6.13.1 Gerresheimer Company Information
- 6.13.2 Gerresheimer Business Overview
- 6.13.3 Gerresheimer Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Gerresheimer Glass Vial for Vaccine Product Portfolio
- 6.13.5 Gerresheimer Recent Developments
- 6.14 Four Stars Glass
- 6.14.1 Four Stars Glass Company Information
- 6.14.2 Four Stars Glass Business Overview
- 6.14.3 Four Stars Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Four Stars Glass Glass Vial for Vaccine Product Portfolio
- 6.14.5 Four Stars Glass Recent Developments
- 6.15 JOTOP Glass
- 6.15.1 JOTOP Glass Company Information
- 6.15.2 JOTOP Glass Business Overview
- 6.15.3 JOTOP Glass Glass Vial for Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 JOTOP Glass Glass Vial for Vaccine Product Portfolio
- 6.15.5 JOTOP Glass Recent Developments
7 North America by Country
- 7.1 North America Glass Vial for Vaccine Sales by Country
- 7.1.1 North America Glass Vial for Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Glass Vial for Vaccine Sales by Country (2021-2026)
- 7.1.3 North America Glass Vial for Vaccine Sales Forecast by Country (2027-2032)
- 7.2 North America Glass Vial for Vaccine Market Size by Country
- 7.2.1 North America Glass Vial for Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Glass Vial for Vaccine Market Size by Country (2021-2026)
- 7.2.3 North America Glass Vial for Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Glass Vial for Vaccine Sales by Country
- 8.1.1 Europe Glass Vial for Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Glass Vial for Vaccine Sales by Country (2021-2026)
- 8.1.3 Europe Glass Vial for Vaccine Sales Forecast by Country (2027-2032)
- 8.2 Europe Glass Vial for Vaccine Market Size by Country
- 8.2.1 Europe Glass Vial for Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Glass Vial for Vaccine Market Size by Country (2021-2026)
- 8.2.3 Europe Glass Vial for Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Glass Vial for Vaccine Sales by Country
- 9.1.1 Asia-Pacific Glass Vial for Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Glass Vial for Vaccine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Glass Vial for Vaccine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Glass Vial for Vaccine Market Size by Country
- 9.2.1 Asia-Pacific Glass Vial for Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Glass Vial for Vaccine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Glass Vial for Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Glass Vial for Vaccine Sales by Country
- 10.1.1 South America Glass Vial for Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Glass Vial for Vaccine Sales by Country (2021-2026)
- 10.1.3 South America Glass Vial for Vaccine Sales Forecast by Country (2027-2032)
- 10.2 South America Glass Vial for Vaccine Market Size by Country
- 10.2.1 South America Glass Vial for Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Glass Vial for Vaccine Market Size by Country (2021-2026)
- 10.2.3 South America Glass Vial for Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Glass Vial for Vaccine Sales by Country
- 11.1.1 Middle East and Africa Glass Vial for Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Glass Vial for Vaccine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Glass Vial for Vaccine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Glass Vial for Vaccine Market Size by Country
- 11.2.1 Middle East and Africa Glass Vial for Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Glass Vial for Vaccine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Glass Vial for Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Glass Vial for Vaccine Value Chain Analysis
- 12.1.1 Glass Vial for Vaccine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Glass Vial for Vaccine Production Mode & Process
- 12.2 Glass Vial for Vaccine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Glass Vial for Vaccine Distributors
- 12.2.3 Glass Vial for Vaccine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst